Here’s the latest on Mark Cuban’s online pharmacy efforts.
Mark Cuban Cost Plus Drug Company (Cost Plus Drug Co.) has been active since 2022, aiming to cut prescription drug costs by offering transparent pricing and directly stocking generics. Recent coverage emphasizes its growth, with millions of customers served and thousands of additional medications added to its catalog over time.
Studies and industry coverage through 2024–2025 highlighted significant potential savings for Medicare Part D users and broader price transparency gains, though the model remains subject to ongoing scrutiny and adoption dynamics. For example, researchers reported substantial Medicare Part D savings when comparing Cost Plus Drug pricing to standard Part D costs in prior analyses , and media profiles note rapid expansion in drug offerings and patient reach .
Recent developments suggest Cuban’s approach has influenced broader conversations about the role of middlemen in drug pricing and has prompted collaborations and additional investments in related healthcare access initiatives, though concrete consumer impact varies by region and payer dynamics.
If you’d like, I can pull the most up-to-date articles from specific outlets (e.g., major networks or healthcare trade pubs) and summarize any new milestones, partnerships, or regulatory updates with direct quotes.
In a fireside chat at the University of Pennsylvania, Mark Cuban and Ezekiel Emanuel discuss Cuban’s new company that is disrupting the U.S. prescription drug distribution market.
ldi.upenn.eduAt the 2025 “Future of Health” event hosted by the Wall Street Journal, Mark Cuban shared how PBMs contribute to high drug prices.
healthtree.orgThe billionaire entrepreneur and owner of the Dallas Mavericks has launched the Cost Plus Drug Company, which aims to disrupt the half-trillion-dollar prescription drug market.
www.cbsnews.comBillionaire entrepreneur Mark Cuban recently announced his latest, ground-breaking innovation, and it’s one that should catch the attention of Americans.
fee.orgMark Cuban's latest investment in the pharmaceutical industry offers common generic prescription medications (not including insulin) at a fraction of the cost.
beyondtype1.orgMark Cuban, latest effort is not just another start-up; it’s a multi-pronged assault on healthcare’s stubborn pillars
meyka.comThe billionaire entrepreneur and owner of the Dallas Mavericks has launched the Cost Plus Drug Company, which aims to disrupt the half-trillion-dollar prescription drug market.
www.cbsnews.comAs the healthcare debate rages on, Mark Cuban offers industry insider insight on ongoing issues and how legislators could potentially solve it.
www.barchart.com